期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
单核细胞趋化蛋白1在前列腺癌进展中的调节作用 被引量:3
1
作者 陈昆 韩前河 +2 位作者 张楠 单中杰 管庆军 《中国现代医学杂志》 CAS 2018年第27期22-28,共7页
目的探讨单核细胞趋化蛋白1(MCP-1)在前列腺癌进展中的作用。方法采用免疫组织化学(简称免疫组化)检测MCP-1和血管紧张素Ⅱ1型受体(AT1R)在前列腺癌细胞系LNCa P,C4-2和C4-2AT6中的表达。ELISA检测AngⅡ和CV11974(AT1R阻断剂)对前列腺... 目的探讨单核细胞趋化蛋白1(MCP-1)在前列腺癌进展中的作用。方法采用免疫组织化学(简称免疫组化)检测MCP-1和血管紧张素Ⅱ1型受体(AT1R)在前列腺癌细胞系LNCa P,C4-2和C4-2AT6中的表达。ELISA检测AngⅡ和CV11974(AT1R阻断剂)对前列腺癌细胞系中MCP-1生成的影响。在C4-2AT6细胞中,ELISA检测AngⅡ和LY294002(PI3K抑制剂)对MCP-1生成的影响,Western blot检测AngⅡ和CV11974对Akt蛋白磷酸化水平(p-Akt)的影响,免疫组化检测TCV116(AT1R阻断剂)对C4-2AT6细胞中MCP-1和F4/80+表达的影响。免疫组化检测前列腺癌患者组织中MCP-1和CD68的表达。结果 MCP-1和AT1R在前列腺癌细胞系LNCaP,C4-2和C4-2AT6中均表达,且在C4-2AT6中表达最高。在C4-2和C4-2AT6细胞中,AngⅡ能够增加MCP-1生成(P <0.05),而CV11974则能够逆转AngⅡ介导的MCP-1生成增加(P <0.05)。在C4-2AT6细胞中,LY294002逆转了AngⅡ介导的MCP-1生成增加(P <0.05),CV11974能够逆转AngⅡ介导的p-Akt增加。TCV116可降低C4-2AT6细胞中MCP-1和F4/80+的表达(P <0.05)。前列腺癌患者组织中MCP-1和CD68的表达与前列腺癌的恶性程度有关,格里森分数越高,MCP-1和CD68的表达越高。结论 MCP-1可通过AT1R-PI3K/Akt信号通路在前列腺癌恶性进展中发挥重要作用。 展开更多
关键词 单核细胞趋化蛋白1 血管紧张素Ⅱ1型受体 前列腺癌
下载PDF
Relationship between gene polymorphisms and prostate cancer risk
2
作者 Qian-He Han zhong-jie shan +2 位作者 Jian-Ting Hu Nan Zhang Xue-Pei Zhang 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第7期566-570,共5页
Objective: To investigate the relationship between genetic factor and prostate cancer(Pca) risk and the possible cause in it. Methods: The polymorphisms of cytochrome P450 family 17(CYPl7) rs743572, p27 V109 G and and... Objective: To investigate the relationship between genetic factor and prostate cancer(Pca) risk and the possible cause in it. Methods: The polymorphisms of cytochrome P450 family 17(CYPl7) rs743572, p27 V109 G and androgen receptor(AR) gene CAG repeat length in peripheral blood from 70 cases and 70 controls were detected through the polymerase chain reaction-restriction fragment length polymorphism technique or short tandem repeatpolymerase chain reaction technique. Then, according to the results of case-control study, the recombinant plasmids containing the wild/mutant p27 gene were constructed and transfected Pca LNcap cells. After 24 and 72 h of transfection, the cell proliferative activity was determined by MTT method, cell cycle distribution and apoptosis was detected by flow cytometry, and the expression level of bcl-2, caspase-3 and p27 protein was determined by Western-blot. Results:In three target polymorphisms, only p27 V109 G polymorphism was related to Pca risk(P=0.030, OR=0.202, 95% CI=0.042-0.973). Pca risk of p27-109 G allele was lower than-109 V allele(P=0.006, OR=0.285, 95% CI=0.110-0.737). Cells transfected with wild/mutant p27 gene both showed the higher cells apoptosis rate and the lower cell proliferative activity than mock cells(P<0.05 or 0.01), the regulatory effect of mutant p27 on cell proliferation and apoptosis was stronger than the wild p27(P<0.05). Conclusions: p27-109 G allele that could cause higher p27 protein expression than-109 V allele in LNcap cells, maybe is the protective factor of Pca. 展开更多
关键词 PROSTATE cancer CASE-CONTROL study P27 V109G polymorphism LNCAP cells
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部